Teva Pharmaceutical Industries' new CEO Jeremy Levin speaks during a news conference in Tel Aviv May 9, 2012. Teva Pharmaceutical Industries posted a 40 percent jump in quarterly profit that beat estimates,
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Dimite el CEO del laboratorio Teva en medio de una crisis de confianza | Reuters
23 Teva Pharmaceuticals Open New Logistic Centre In Israel Photos and Premium High Res Pictures - Getty Images
/cloudfront-us-east-2.images.arcpublishing.com/reuters/G5JWOXLOQZIDLHFUUAR3HXPXEQ.jpg "Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters")
Teva hires ex-Novartis executive to succeed CEO Schultz | Reuters
Teva Pharma nombra nuevo CEO al presidente ejecutivo de Lundbeck
Teva CEO Erez Vigodman Steps Down | CHEManager
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva CEO Kåre Schultz discusses company's latest quarter and opioid settlement - YouTube
Teva CEO reportedly wanted to stay in his job | The Times of Israel
In letter to Israeli PM, Teva CEO apologizes for drug-maker's sorry state | The Times of Israel
Teva's Richard Francis launches 'pivot to growth' strategy | Fox Business Video
Kåre Schultz is Named New President & CEO of Teva Pharmaceutical
Teva has made short work of its hunt for a new CEO
352 fotos e imágenes de Hans Hartmann - Getty Images
Teva Pharmaceutical CEO Talks Opioids, Lawsuits, and the Long Road Ahead | Barron's
Where is Kåre Schultz? | Ctech
Analysis: Teva Pharmaceuticals is bogged down by legal issues, fails to kick-start growth | Ctech
Teva CEO Kare Schultz's pay fell in 2021 - Globes
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
CEO global de Teva arrancó en 2023 | PharmaBiz.NET
Teva - Wikipedia, la enciclopedia libre
Teva CEO Vigodman Steps Down After Poor Outlook for 2017 | Fortune
Yitzhak Peterburg, nuevo CEO y presidente interino de Teva Pharmaceutical
Teva Pharma Appoints Novartis, Biogen Vet as New President and CEO | BioSpace
